135
Views
29
CrossRef citations to date
0
Altmetric
Original Research

Interaction of poly-l-lysine coating and heparan sulfate proteoglycan on magnetic nanoparticle uptake by tumor cells

, , , , &
Pages 1693-1706 | Published online: 20 Mar 2018

References

  • HoshyarNGraySHanHBaoGThe effect of nanoparticle size on in vivo pharmacokinetics and cellular interactionNanomedicine (Lond)201611667369227003448
  • ZhangSGaoHBaoGPhysical principles of nanoparticle cellular endocytosisACS Nano2015998655867126256227
  • ZhuLZhouZMaoHYangLMagnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapyNanomedicine (Lond)2016121738727876448
  • SinghDMcMillanJMKabanovAVSokolsky-PapkovMGendelmanHEBench-to-bedside translation of magnetic nanoparticlesNanomedicine (Lond)201494501516
  • EstelrichJEscribanoEQueraltJBusquetsMAIron oxide nanoparticles for magnetically-guided and magnetically-responsive drug deliveryInt J Mol Sci20151648070810125867479
  • LuYCChangFYTuSJChenJPMaYHCellular uptake of magnetite nanoparticles enhanced by NdFeB magnets in staggered arrangementJ Magn Magn Mater20174277180
  • UlbrichKHoláKŠubrVBakandritsosATučekJZbořilRTargeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studiesChem Rev201611695338543127109701
  • KhanMAWuVMGhoshSUskokovićVGene delivery using calcium phosphate nanoparticles: optimization of the transfection process and the effects of citrate and poly(l-lysine) as additivesJ Colloid Interf Sci20164714858
  • JinHYuYChrislerWBXiongYHuDLeiCDelivery of microRNA-10b with polylysine nanoparticles for inhibition of breast cancer cell wound healingBreast Cancer (Auckl)2012691922259248
  • AskarianSAbnousKTaghaviSOskueeRKRamezaniMCellular delivery of shRNA using aptamer-conjugated PLL-alkyl-PEI nanoparticlesColloids Surf B Biointerfaces201513635536426433348
  • WangXZhangHJingHCuiLHighly efficient labeling of human lung cancer cells using cationic poly-l-lysine -assisted magnetic iron oxide nanoparticlesNano Micro Lett201574374384
  • WangXWeiFLiuACancer stem cell labeling using poly(l-lysine)-modified iron oxide nanoparticlesBiomaterials201233143719373222342710
  • BabičMHorákDTrchováMPoly(l-lysine)-modified iron oxide nanoparticles for stem cell labelingBioconjug Chem200819374075018288791
  • BabičMSchmiedtováMPoledneRHerynekVHorákDIn vivo monitoring of rat macrophages labeled with poly(l-lysine)-iron oxide nanoparticlesJ Biomed Mater Res B Appl Biomater201510361141114825283523
  • MishraSKKhushuSGangenahalliGPotential stem cell labeling ability of poly-l-lysine complexed to ultrasmall iron oxide contrast agent: an optimization and relaxometry studyExp Cell Res2015339242743626589263
  • FrankJAMillerBRArbabASClinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agentsRadiology2003228248048712819345
  • ArbabASBashawLAMillerBRCharacterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imagingRadiology2003229383884614657318
  • HanGWuSWangJGengXLiuGpoly-l-lysine mediated synthesis of gold nanoparticles and biological effectsJ Nanosci Nanotechnol20151596503650826716205
  • AlbukhatySNaderi-ManeshHTiraihiTIn vitro labeling of neural stem cells with poly-l-lysine coated super paramagnetic nanoparticles for green fluorescent protein transfectionIran Biomed J2013172717623567848
  • PongracIMDobrivojevićMAhmedLBImproved biocompatibility and efficient labeling of neural stem cells with poly(l-lysine)-coated maghemite nanoparticlesBeilstein J Nanotechnol2016792693627547609
  • RiggioCCalatayudMPHoskinsCpoly-l-lysine -coated magnetic nanoparticles as intracellular actuators for neural guidanceInt J Nanomedicine201273155316622811603
  • HengBCCowanCMDavalianDElectrostatic binding of nanoparticles to mesenchymal stem cells via high molecular weight polyelectrolyte chainsJ Tissue Eng Regen Med20093424325419283725
  • BushCAMartin-PastorMImbertyAStructure and conformation of complex carbohydrates of glycoproteins, glycolipids, and bacterial polysaccharidesAnnu Rev Biophys Biomol Struct19992826929310410803
  • DreyfussJLRegatieriCVJarrougeTRCavalheiroRPSampaioLONaderHBHeparan sulfate proteoglycans: structure, protein interactions and cell signalingAn Acad Bras Cienc200981340942919722012
  • MythreyeKBlobeGCProteoglycan signaling co-receptors: roles in cell adhesion, migration and invasionCell Signal200921111548155819427900
  • LinXFunctions of heparan sulfate proteoglycans in cell signaling during developmentDevelopment2004131246009602115563523
  • ChristiansonHCBeltingMHeparan sulfate proteoglycan as a cell-surface endocytosis receptorMatrix Biol201435515524145152
  • ZarskaMNovotnyFHavelFTwo-step mechanism of cellular uptake of cationic gold nanoparticles modified by (16-mercaptohexadecyl)trimethylammonium bromideBioconjug Chem201627102558257427602782
  • BeltingMHeparan sulfate proteoglycan as a plasma membrane carrierTrends Biochem Sci200328314515112633994
  • ChengMJKumarRSridharSWebsterTJEbongEEEndothelial glycocalyx conditions influence nanoparticle uptake for passive targetingInt J Nanomedicine2016113305331527499624
  • NasimuzzamanMPersonsDACell membrane-associated heparan sulfate is a receptor for prototype foamy virus in human, monkey, and rodent cellsMol Ther20122061158116622434139
  • JonesKSPetrow-SadowskiCBertoletteDCHuangYRuscettiFWHeparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cellsJ Virol20057920126921270216188972
  • UrbinatiCNicoliSGiaccaMHIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endotheliumBlood2009114153335334219661268
  • TyagiMRusnatiMPrestaMGiaccaMInternalization of HIV-1 tat requires cell surface heparan sulfate proteoglycansJ Biol Chem200127653254326111024024
  • ConnellBJLortat-JacobHHuman immunodeficiency virus and heparan sulfate: from attachment to entry inhibitionFront Immunol2013438524312095
  • WangHMaJYangYZengFLiuCHighly efficient delivery of functional cargoes by a novel cell-penetrating peptide derived from SP140-like proteinBioconjug Chem20162751373138127070736
  • SomiyaMLiuQYoshimotoNCellular uptake of hepatitis B virus envelope L particles is independent of sodium taurocholate cotransporting polypeptide, but dependent on heparan sulfate proteoglycanVirology2016497233227420796
  • LuYCLuoPCHuangCWAugmented cellular uptake of nanoparticles using tea catechins: effect of surface modification on nanoparticle-cell interactionNanoscale2014617102971030625069428
  • KimHSQuonMJKimJANew insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallateRedox Biol2014218719524494192
  • AfzalMSaferAMMenonMGreen tea polyphenols and their potential role in health and diseaseInflammopharmacology201523415116126164000
  • SinghBNShankarSSrivastavaRKGreen tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applicationsBiochem Pharmacol201182121807182121827739
  • FujimuraYSumidaMSugiharaKTsukamotoSYamadaKTachibanaHGreen tea polyphenol EGCG sensing motif on the 67-kDa laminin receptorPLoS One201275e3794222666419
  • TachibanaHKogaKFujimuraYYamadaKA receptor for green tea polyphenol EGCGNat Struct Mol Biol200411438038115024383
  • ChristiansonHCSvenssonKJvan KuppeveltTHLiJPBeltingMCancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activityProc Natl Acad Sci U S A201311043173801738524101524
  • KouLSunJZhaiYHeZThe endocytosis and intracellular fate of nanomedicines: implication for rational designAsian J Pharmacol20138110
  • SigismundSConfalonieriSCilibertoAPoloSScitaGDi FiorePPEndocytosis and signaling: cell logistics shape the eukaryotic cell planPhysiol Rev201292127336622298658
  • HuQKangTFengJTumor microenvironment and angiogenic blood vessels dual-targeting for enhanced anti-glioma therapyACS Appl Mater Interfaces2016836235682357927580101
  • LiZShuaiCLiXLiXXiangJLiGMechanism of poly-l-lysine -modified iron oxide nanoparticles uptake into cellsJ Biomed Mater Res A2013101102846285023504952
  • KatebiSEsmaeiliAGhaediKStatic magnetic field reduced exogenous oligonucleotide uptake by spermatozoa using magnetic nanoparticle gene delivery systemJ Magn Magn Mater2016402184189
  • ShanehsazzadehSLahootiAHajipourMJGhavamiMAzhdarzadehMExternal magnetic fields affect the biological impacts of superparamagnetic iron nanoparticlesColloids Surf B Biointerfaces20151361107111226613856
  • WangQMWangHLiYFInhibition of EMMPRIN and MMP-9 expression by epigallocatechin-3-gallate through 67-kDa laminin receptor in PMA-induced macrophagesCell Physiol Biochem20163962308231927832636
  • PyrgiotakisGBlattmannCODemokritouPReal-time nanoparticle-cell interactions in physiological media by atomic force microscopyACS Sustain Chem Eng2014271681169025068097
  • FurlaniEPXueXField, force and transport analysis for magnetic particle-based gene deliveryMicrofluid Nanofluidics2012134589602
  • NicolsonGLThe fluid-mosaic model of membrane structure: still relevant to understanding the structure, function and dynamics of biological membranes after more than 40 yearsBiochim Biophys Acta2014183861451146624189436